Your browser doesn't support javascript.
loading
Central adrenal insufficiency: who, when, and how? From the evidence to the controversies - an exploratory review.
Bitencourt, Mariana Rechia; Batista, Rafael Loch; Biscotto, Isabela; Carvalho, Luciani R.
Afiliação
  • Bitencourt MR; Unidade de Endocrinologia do Desenvolvimento, Disciplina de Endocrinologia, Departamento de Clínica Médica, Hospital das Clínicas, Faculdade de Medicina, Universidade São Paulo, São Paulo, SP, Brasil, marianarechia@usp.br.
  • Batista RL; Unidade de Endocrinologia do Desenvolvimento, Disciplina de Endocrinologia, Departamento de Clínica Médica, Hospital das Clínicas, Faculdade de Medicina, Universidade São Paulo, São Paulo, SP, Brasil.
  • Biscotto I; Instituto do Câncer do Estado de São Paulo, São Paulo, SP, Brasil.
  • Carvalho LR; Faculdade de Ciências Médicas e da Saúde de Juiz de Fora (Suprema), Juiz de Fora, MG, Brasil.
Arch Endocrinol Metab ; 66(4): 541-550, 2022.
Article em En | MEDLINE | ID: mdl-35758836
ABSTRACT
Central adrenal insufficiency (CAI) is a life-threatening disorder. This occurs when ACTH production is insufficient, leading to low cortisol levels. Since corticosteroids are crucial to many metabolic responses under organic stress and inflammatory conditions, CAI recognition and prompt treatment are vital. However, the diagnosis of CAI is challenging. This is not only because its clinical presentation is usually oligosymptomatic, but also because the CAI laboratory investigation presents many pitfalls. Thus, the clarification of when to use each test could be helpful in many contexts. The CAI challenge is also involved in treatment Several formulations of synthetic steroids exist, followed by the lack of a biomarker for glucocorticoid replacement. This review aims to access all available literature to synthesize important topics about who should investigate CAI, when it should be suspected, and how CAI must be treated.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hidrocortisona / Insuficiência Adrenal Limite: Humans Idioma: En Revista: Arch Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hidrocortisona / Insuficiência Adrenal Limite: Humans Idioma: En Revista: Arch Endocrinol Metab Ano de publicação: 2022 Tipo de documento: Article